CSI Market
Sign In | Register

Capricor Therapeutics inc (CAPR) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access CAPR Annual Cash Flow →
The table below presents a historical view of Capricor Therapeutics inc's cash flow activity, supporting analysis of liquidity trends over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2026)
3 Months 		(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Operating Activities
Income-33.94
Depreciation & amortization0.53
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.00
Goodwill, Impairment Loss0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property0.00
Share-based Compensation5.92
Income (Loss) from Equity Method Investments0.00
Increase (Decrease) in Restricted Cash for Operating Activities0.00
Increase Decrease From Grants Receivable0.06
Impairment Of Intangible Assets Excluding Goodwill-
Increase Decrease In Accounts Payable And Accrued Liabilities Related Party-
Amortization Or Accretion Of Debt Discount Premium-0.36
Noncash Lease Expenses0.64
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Other Accounts Payable and Accrued Liabilities-3.08
Increase (Decrease) in Due to Related Parties, Current0.00
Increase (Decrease) in Interest Payable, Net0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.98
Other Working Capital0.00
Other Noncash Income (Expense)-0.01
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities-29.25
Investing Activities
Capital Expenditures-5.12
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities31.00
Payments to Acquire Marketable Securities-174.89
Real Estate Investments0.00
Proceeds From Sales Of Assets-
Proceeds From Reverse Merger-
Payments For Patents-
Payments To Acquire Leasehold Improvements-0.92
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net-4.70
Discontinued operations0.00
Net Cash Flow from Investing Activities-154.64
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock1.47
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Increase (Decrease) in Deposits Outstanding0.00
Other financing activities net0.00
Other net0.00
Proceeds From Stock Option And Warrant Excercises-
Proceeds From Stock Option And Warrant Exercises-
Payment Of Preferred Stock And Warrant Issuance Cost-
Proceeds From Stock Options And Warrant Exercises-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities1.47
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-34.38
Total Cash Flow-182.43
4 historic quarters locked

Sign in to unlock the full Capricor Therapeutics inc cash flow history.

Sign In Create Free Account

About Capricor Therapeutics Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001104659-26-097294

Figures are derived from filed reports and may be restated. Historical data is subject to revision.